Ascentage Pharma Group Internat Stock Forecast

Sell candidate since May 08, 2026 Loss -22.00%

The Ascentage Pharma Group Internat stock price fell by -1.64% on the last day (Friday, 26th Jun 2026) from $17.05 to $16.77. During the last trading day the stock fluctuated 4.71% from a day low at $16.36 to a day high of $17.13. The price has been going up and down for this period, and there has been a -1.99% loss for the last 2 weeks. Volume has increased on the last day by 188 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 195 thousand shares were bought and sold for approximately $3.28 million.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $17.26 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -38.99% during the next 3 months and, with a 90% probability hold a price between $7.32 and $10.53 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

AAPG Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Ascentage Pharma Group Internat stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $17.04 and $18.79. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 06, 2026, and so far it has fallen -38.82%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Ascentage Pharma Group Internat stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.770 between high and low, or 4.71%. For the last week, the stock has had daily average volatility of 2.45%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AAPG) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Ascentage Pharma Group Internat to open at $16.75, and during the day (based on 14 day Average True Range), to move between $16.44 and $17.10, which gives a possible trading interval of +/-$0.652 (+/-3.96%) up or down from last closing price. If Ascentage Pharma Group Internat takes out the full calculated possible swing range there will be an estimated 3.96% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $17.01, some $0.240 (1.43%) from the current price of $16.77, our system finds the risk reward not very attractive.

Is Ascentage Pharma Group Internat stock A Buy?

Ascentage Pharma Group Internat holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.313 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $16.75 ( 0.0994%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk